RXC004 is an Orally Active Wnt Inhibitor for Cancer Research
Wnt pathway aberrations are common in gastrointestinal cancers. There are canonical Wnt pathway and noncanonical Wnts. First of all, the canonical Wnt pathway is activated via canonical Wnt ligands binding…